(NP (NP (NN Activation)) (PP (IN of) (NP (NP (JJ nuclear) (NN factor)) (PP (IN of) (NP (VBN activated) (NN T) (NNS cells))))) (PP (IN in) (NP (DT a) (ADJP (NN cyclosporin) (JJ A-resistant)) (NN pathway))) (. .))
(S (NP-SBJ (NP (DT The) (NN mechanism)) (PP (IN of) (NP (NP (NN action)) (PP (IN of) (NP (DT the) (JJ immunosuppressive) (NN drug) (NP (NP (NN cyclosporin) (NN A)) (PRN (-LRB- -LRB-) (NP (NN CsA)) (-RRB- -RRB-)))))))) (VP (VBZ is) (NP-PRD (NP (DT the) (NN inactivation)) (PP (IN of) (NP (DT the) (JJ (calmodulin-dependent Ca2+)) (NN serine-threonine) (NN phosphatase) (NN calcineurin))) (PP (IN by) (NP (DT the) (JJ drug-immunophilin) (NN complex))))) (. .))
(S (NP-SBJ-49 (JJ Inactive) (NN calcineurin)) (VP (VBZ is) (ADJP-PRD (JJ unable) (S (NP-SBJ (-NONE- *-49)) (VP (TO to) (VP (VB activate) (NP (NP (NP (NP (DT the) (JJ nuclear) (NN factor)) (PP (IN of) (NP (VBN activated) (NN T) (NNS cells)))) (PRN (-LRB- -LRB-) (NP (NN NFAT)) (-RRB- -RRB-))) (, ,) (NP (NP (DT a) (NN transcription) (NN factor)) (VP (VBN required) (NP (-NONE- *)) (PP (IN for) (NP (NP (NN expression)) (PP (IN of) (NP (DT the) (NP (NP (NN interleukin) (CD 2)) (PRN (-LRB- -LRB-) (NP (NN IL-2)) (-RRB- -RRB-))) (NN gene))))))))))))) (. .))
(S (NP-SBJ-50 (NP (NN IL-2) (NN production)) (PP (IN by) (NP (JJ CsA-treated) (NNS cells)))) (VP (VBZ is) (ADVP (RB therefore)) (VP (ADVP (RB dramatically)) (VBN reduced) (NP (-NONE- *-50)))) (. .))
(S (NP-SBJ (PRP We)) (VP (VBP demonstrate) (ADVP (RB here)) (, ,) (ADVP (RB however)) (, ,) (SBAR (IN that) (S (S-COOD (S (NP-SBJ-51 (NN NFAT)) (VP (MD can) (VP (VB be) (VP (VBN activated) (NP (-NONE- *-51)))))) (, ,) (CC and) (S (NP-SBJ-52 (NP (JJ significant) (NNS levels)) (PP (IN of) (NP (NN IL-2)))) (VP (MD can) (VP (VB be) (VP (VBN produced) (NP (-NONE- *-52))))))) (PP (IN by) (NP-LGS (DT the) (JJ CsA-resistant) (JJ CD28-signaling) (NN pathway)))))) (. .))
(S-COOD (S (PP (IN In) (NP (JJ transient) (NN transfection) (NNS assays))) (, ,) (NP-SBJ-53 (NP-COOD (CC both) (NP (JJ multicopy) (NN NFAT-) (NP (-NONE- *RNR*-54))) (CC and) (NP (NN IL-2) (NN promoter-beta-galactosidase) (NN reporter) (NN gene) (NP (-NONE- *RNR*-54)))) (NP-54 (NNS constructs))) (VP (MD could) (VP (VB be) (VP (VBN activated) (NP (-NONE- *-53)) (PP (IN by) (NP-LGS (NN phorbol) (NN 12-myristate) (NN 13-acetate) (-LRB- -LRB-) (NN PMA) (-RRB- -RRB-) (NN /alpha-CD28) (NN stimulation))))))) (, ,) (CC and) (S (NP-SBJ (DT this) (NN activation)) (VP (VBD was) (ADJP-PRD (JJ resistant) (PP (TO to) (NP (NN CsA)))))) (. .))
(S (NP-SBJ (JJ Electrophoretic) (NN mobility) (NN shift) (NN assay)) (VP (VBD showed) (NP (NP (DT the) (NN induction)) (PP (IN of) (NP (DT a) (JJ CsA-resistant) (NN NFAT) (NN complex))) (PP (IN in) (NP (NP (DT the) (JJ nuclear) (NNS extracts)) (PP (IN of) (NP (NP (JJ peripheral) (NN blood) (NN T) (NNS cells)) (VP (VBN stimulated) (NP (-NONE- *)) (PP (IN with) (NP-COOD (NP (NN PMA)) (CC plus) (NP (NN alphaCD28))))))))))) (. .))
(S (NP-SBJ (NP (JJ Peripheral) (NN blood) (NN T) (NNS cells)) (VP (VBN stimulated) (NP (-NONE- *)) (PP (IN with) (NP (NN (alphaCD28 PMA)))))) (VP (VBD produced) (NP (NN IL-2)) (PP (IN in) (DT the) (NN presence) (IN of) (NP (NN CsA)))) (. .))
(S (ADVP (RB Collectively)) (, ,) (NP-SBJ (DT these) (NNS data)) (VP (VBP suggest) (SBAR (IN that) (S (S-COOD (S (NP-SBJ-55 (NN NFAT)) (VP (MD can) (VP (VB be) (VP (VBN activated) (NP (-NONE- *-55)))))) (CC and) (S (NP-SBJ-56 (NN IL-2)) (VP (MD can) (VP (VB be) (VP (VBN produced) (NP (-NONE- *-56))))))) (PP (IN in) (NP (DT a) (ADJP (NN calcineurin) (JJ independent)) (NN manner)))))) (. .))
